Bobbi Jo H Yarborough1, Scott P Stumbo2, Shannon L Janoff3, Micah T Yarborough4, Dennis McCarty5, Howard D Chilcoat6, Paul M Coplan7, Carla A Green8. 1. Kaiser Permanente Northwest Center for Health Research, 3800 N Interstate Ave, Portland, OR 97227, USA. Electronic address: bobbijo.h.yarborough@kpchr.org. 2. Kaiser Permanente Northwest Center for Health Research, 3800 N Interstate Ave, Portland, OR 97227, USA. Electronic address: scott.p.stumbo@kpchr.org. 3. Kaiser Permanente Northwest Center for Health Research, 3800 N Interstate Ave, Portland, OR 97227, USA. Electronic address: shannon.l.janoff@kpchr.org. 4. Kaiser Permanente Northwest Center for Health Research, 3800 N Interstate Ave, Portland, OR 97227, USA. Electronic address: micah.yarborough@kpchr.org. 5. Department of Public Health & Preventive Medicine, Oregon Health & Science University, 3181 S.W. Sam Jackson Hill Road, CB 669, Portland, OR 97239, USA. Electronic address: mcartyd@ohsu.edu. 6. Purdue Pharma, L.P. One Stamford Forum, Stamford, CT 06901, USA. Electronic address: howard.chilcoat@pharma.com. 7. Purdue Pharma, L.P. One Stamford Forum, Stamford, CT 06901, USA. Electronic address: paul.coplan@pharma.com. 8. Kaiser Permanente Northwest Center for Health Research, 3800 N Interstate Ave, Portland, OR 97227, USA. Electronic address: carla.a.green@kpchr.org.
Abstract
BACKGROUND: Opioid abuse and misuse are significant public health issues. The CDC estimated 72% of pharmaceutical-related overdose deaths in the US in 2012 involved opioids. While studies of opioid overdoses have identified sociodemographic characteristics, agents used, administration routes, and medication sources associated with overdoses, we know less about the context and life circumstances of the people who experience these events. METHODS: We analyzed interviews (n=87) with survivors of opioid overdoses or family members of decedents. Individuals experiencing overdoses were members of a large integrated health system. Using ICD codes for opioid overdoses and poisonings, we identified participants from five purposefully derived pools of health-plan members who had: 1) prescriptions for OxyContin(®) or single-ingredient sustained-release oxycodone, 2) oxycodone single-ingredient immediate release, 3) other long-acting opioids, 4) other short-acting opioids, or 5) no active opioid prescriptions. RESULTS: Individuals who experienced opioid overdoses abused and misused multiple medications/drugs; experienced dose-related miscommunications or medication-taking errors; had mental health and/or substance use conditions; reported chronic pain; or had unstable resources or family/social support. Many had combinations of these risks. Most events involved polysubstance use, often including benzodiazepines. Accidental overdoses were commonly the result of abuse or misuse, some in response to inadequately treated chronic pain or, less commonly, medication-related mistakes. Suicide attempts were frequently triggered by consecutive negative life events. CONCLUSIONS: To identify people at greater risk of opioid overdose, efforts should focus on screening for prescribed and illicit polysubstance use, impaired cognition, and changes in life circumstances, psychosocial risks/supports, and pain control.
BACKGROUND:Opioid abuse and misuse are significant public health issues. The CDC estimated 72% of pharmaceutical-related overdose deaths in the US in 2012 involved opioids. While studies of opioid overdoses have identified sociodemographic characteristics, agents used, administration routes, and medication sources associated with overdoses, we know less about the context and life circumstances of the people who experience these events. METHODS: We analyzed interviews (n=87) with survivors of opioid overdoses or family members of decedents. Individuals experiencing overdoses were members of a large integrated health system. Using ICD codes for opioid overdoses and poisonings, we identified participants from five purposefully derived pools of health-plan members who had: 1) prescriptions for OxyContin(®) or single-ingredient sustained-release oxycodone, 2) oxycodone single-ingredient immediate release, 3) other long-acting opioids, 4) other short-acting opioids, or 5) no active opioid prescriptions. RESULTS: Individuals who experienced opioid overdoses abused and misused multiple medications/drugs; experienced dose-related miscommunications or medication-taking errors; had mental health and/or substance use conditions; reported chronic pain; or had unstable resources or family/social support. Many had combinations of these risks. Most events involved polysubstance use, often including benzodiazepines. Accidental overdoses were commonly the result of abuse or misuse, some in response to inadequately treated chronic pain or, less commonly, medication-related mistakes. Suicide attempts were frequently triggered by consecutive negative life events. CONCLUSIONS: To identify people at greater risk of opioid overdose, efforts should focus on screening for prescribed and illicit polysubstance use, impaired cognition, and changes in life circumstances, psychosocial risks/supports, and pain control.
Authors: Emily Hurstak; Julene K Johnson; Lina Tieu; David Guzman; Claudia Ponath; Christopher T Lee; Christina Weyer Jamora; Margot Kushel Journal: Drug Alcohol Depend Date: 2017-07-04 Impact factor: 4.492
Authors: Ruchir N Karmali; G Thomas Ray; Andrea L Rubinstein; Stacy A Sterling; Constance M Weisner; Cynthia I Campbell Journal: Drug Alcohol Depend Date: 2020-02-20 Impact factor: 4.492
Authors: Tessa Cheng; Will Small; Ekaterina Nosova; Robert Hogg; Kanna Hayashi; Thomas Kerr; Kora DeBeck Journal: Subst Use Misuse Date: 2020-06-26 Impact factor: 2.164
Authors: Christy K Scott; Michael L Dennis; Christine E Grella; Lisa Nicholson; Jamie Sumpter; Rachel Kurz; Rod Funk Journal: J Subst Abuse Treat Date: 2019-08-07
Authors: Michael C Otterstatter; Alexis Crabtree; Sabina Dobrer; Brooke Kinniburgh; Salman Klar; Anthony Leamon; Jennifer May-Hadford; Christopher Mill; Mina Park; Andrew W Tu; Lu Zheng Journal: Health Promot Chronic Dis Prev Can Date: 2018-09 Impact factor: 3.240
Authors: Hilary S Connery; Nadine Taghian; Jungjin Kim; Margaret Griffin; Ian R H Rockett; Roger D Weiss; R Kathryn McHugh Journal: Drug Alcohol Depend Date: 2019-10-05 Impact factor: 4.492